The exact cause of this transformation is not fully understood but may be influenced by autoimmune factors, chronic immune stimulation, and viral infections such as hepatitis C. The role of Bruton tyrosine kinase (BTK) inhibitors (e.g., ibrutinib) also warrants consideration, especially if genetic mutations lead to resistant clones. This evidence concerns the gene BTK and hepatitis C virus infection.